Veteran adherence to oral versus injectable AUD medication treatment.
Hayden StewartBrian G MitchellDaniel AyangaAnnette WalderPublished in: The mental health clinician (2021)
XR naltrexone may improve adherence rates compared with oral naltrexone or disulfiram, but not acamprosate based on these outcomes. Patients may have increased adherence if they are seen more often in clinic and have trialed more AUD medications.
Keyphrases
- alcohol use disorder
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- ejection fraction
- glycemic control
- primary care
- peritoneal dialysis
- healthcare
- patient reported outcomes
- metabolic syndrome
- adipose tissue
- combination therapy
- adverse drug
- hyaluronic acid
- smoking cessation
- replacement therapy
- insulin resistance